Journal of Pharmacology and Experimental Therapeutics: 374 (2)

August 01, 2020; Volume 374,Issue 2

Behavioral Pharmacology

You have access
Pharmacological Properties of δ-Opioid Receptor–Mediated Behaviors: Agonist Efficacy and Receptor Reserve
Isaac J. Dripps, Ruizhuo Chen, Amanda M. Shafer, Kathryn E. Livingston, Alexander Disney, Stephen M. Husbands, John R. Traynor, Kenner C. Rice and Emily M. Jutkiewicz

Journal of Pharmacology and Experimental Therapeutics August 2020, 374 (2) 319-330; DOI: https://doi.org/10.1124/jpet.119.262717

Cellular and Molecular

Open Access
ELX-02 Generates Protein via Premature Stop Codon Read-Through without Inducing Native Stop Codon Read-Through Proteins
Daniel K. Crawford, Iris Alroy, Neal Sharpe, Matthew M. Goddeeris and Greg Williams

Journal of Pharmacology and Experimental Therapeutics August 2020, 374 (2) 264-272; DOI: https://doi.org/10.1124/jpet.120.265595
Open Access
Voltage-Dependent Anion Channels Influence Cytotoxicity of ME-344, a Therapeutic Isoflavone
Leilei Zhang, Danyelle M. Townsend, Morgan Morris, Eduardo N. Maldonado, Yu-Lin Jiang, Ann-Marie Broome, Jennifer R. Bethard, Lauren E. Ball and Kenneth D. Tew

Journal of Pharmacology and Experimental Therapeutics August 2020, 374 (2) 308-318; DOI: https://doi.org/10.1124/jpet.120.000009

Drug Discovery and Translational Medicine

You have access
Lysophosphatidic Acid Receptor Agonism: Discovery of Potent Nonlipid Benzofuran Ethanolamine Structures
Etienne Guillot, Jean-Christophe Le Bail, Pascal Paul, Valérie Fourgous, Pascale Briand, Michel Partiseti, Bruno Cornet, Philip Janiak and Christophe Philippo

Journal of Pharmacology and Experimental Therapeutics August 2020, 374 (2) 283-294; DOI: https://doi.org/10.1124/jpet.120.265454
Open Access
Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease
Ughetta del Balzo, Pierre E. Signore, Gail Walkinshaw, Todd W. Seeley, Mitchell C. Brenner, Qingjian Wang, Guangjie Guo, Michael P. Arend, Lee A. Flippin, F. Aisha Chow, David C. Gervasi, Christian H. Kjaergaard, Ingrid Langsetmo, Volkmar Guenzler, David Y. Liu, Steve J. Klaus, Al Lin and Thomas B. Neff

Journal of Pharmacology and Experimental Therapeutics August 2020, 374 (2) 342-353; DOI: https://doi.org/10.1124/jpet.120.265181

Metabolism, Transport, and Pharmacogenomics

You have access
Heterologous Expression and Functional Characterization of Novel CYP2C9 Variants Identified in the Alaska Native People
Matthew G. McDonald, Lindsay M. Henderson, Sutapa Ray, Catherine K. Yeung, Amanda L. Johnson, John P. Kowalski, Helmut Hanenberg, Constanze Wiek, Kenneth E. Thummel and Allan E. Rettie

Journal of Pharmacology and Experimental Therapeutics August 2020, 374 (2) 233-240; DOI: https://doi.org/10.1124/jpet.120.265850
You have access
In Vitro Inhibition of Human Aldehyde Oxidase Activity by Clinically Relevant Concentrations of Gefitinib and Erlotinib: Comparison with Select Metabolites, Molecular Docking Analysis, and Impact on Hepatic Metabolism of Zaleplon and Methotrexate
Wee Kiat Tan, Alyssa Rui Yi Tan, Punitha Sivanandam, Ernest Jing Hui Goh, Ze Ping Yap, Nur Fazilah Saburulla, Karl Austin-Muttitt, Jonathan G.L. Mullins and Aik Jiang Lau

Journal of Pharmacology and Experimental Therapeutics August 2020, 374 (2) 295-307; DOI: https://doi.org/10.1124/jpet.120.265249

Neuropharmacology

You have access
[³H]Dopamine Uptake through the Dopamine and Norepinephrine Transporters is Decreased in the Prefrontal Cortex of Transgenic Mice Expressing HIV-1 Transactivator of Transcription Protein
Matthew Strauss, Bernadette O’Donovan, Yizhi Ma, Ziyu Xiao, Steven Lin, Michael T. Bardo, Pavel I. Ortinski, Jay P. McLaughlin and Jun Zhu

Journal of Pharmacology and Experimental Therapeutics August 2020, 374 (2) 241-251; DOI: https://doi.org/10.1124/jpet.120.266023
Open Access
MK-8719, a Novel and Selective O-GlcNAcase Inhibitor That Reduces the Formation of Pathological Tau and Ameliorates Neurodegeneration in a Mouse Model of Tauopathy
Xiaohai Wang, Wenping Li, Jacob Marcus, Michelle Pearson, Lixin Song, Karen Smith, Giuseppe Terracina, Julie Lee, Kwok-Lam Karen Hong, Sherry X. Lu, Lynn Hyde, Shu-Cheng Chen, David Kinsley, Jerry P. Melchor, Daniel J. Rubins, Xiangjun Meng, Eric Hostetler, Cyrille Sur, Lili Zhang, Joel B. Schachter, J. Fred Hess, Harold G. Selnick, David J. Vocadlo, Ernest J. McEachern, Jason M. Uslaner, Joseph L. Duffy and Sean M. Smith

Journal of Pharmacology and Experimental Therapeutics August 2020, 374 (2) 252-263; DOI: https://doi.org/10.1124/jpet.120.266122
You have access
3,4-Methylenedioxypyrovalerone: Neuropharmacological Impact of a Designer Stimulant of Abuse on Monoamine Transporters
Charlotte P. Magee, Christopher L. German, Yasmeen H. Siripathane, Peter S. Curtis, David J. Anderson, Diana G. Wilkins, Glen R. Hanson and Annette E. Fleckenstein

Journal of Pharmacology and Experimental Therapeutics August 2020, 374 (2) 273-282; DOI: https://doi.org/10.1124/jpet.119.264895
You have access
Chronic Morphine-Induced Changes in Signaling at the A₃ Adenosine Receptor Contribute to Morphine-Induced Hyperalgesia, Tolerance, and Withdrawal
Timothy M. Doyle, Tally M. Largent-Milnes, Zhoumou Chen, Vasiliki Staikopoulos, Emanuela Esposito, Rebecca Dalgarno, Churmy Fan, Dilip K. Tosh, Salvatore Cuzzocrea, Kenneth A. Jacobson, Tuan Trang, Mark R. Hutchinson, Gary J. Bennett, Todd W. Vanderah and Daniela Salvemini

Journal of Pharmacology and Experimental Therapeutics August 2020, 374 (2) 331-341; DOI: https://doi.org/10.1124/jpet.120.000004

Main menu

User menu

Search

Table of Contents

Behavioral Pharmacology

Cellular and Molecular

Drug Discovery and Translational Medicine

Metabolism, Transport, and Pharmacogenomics

Neuropharmacology

In this issue

Jump to

Navigate

More Information

ASPET's Other Journals